scholarly article | Q13442814 |
P2093 | author name string | Yong Zhang | |
Hai-Jun Li | |||
Lin Fan | |||
E Bai | |||
Xiang-Ming Che | |||
Jun-Ke Fu | |||
P2860 | cites work | Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses | Q24293580 |
Adipose tissue and adipocytes support tumorigenesis and metastasis | Q26826123 | ||
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment | Q27025661 | ||
Global cancer statistics, 2012 | Q27860501 | ||
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 | Q29555853 | ||
The Hippo signaling pathway in stem cell biology and cancer | Q30410176 | ||
A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study | Q30528584 | ||
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients. | Q34107754 | ||
Obesity, Inflammation, and Cancer | Q34527177 | ||
The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals | Q34608304 | ||
Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions | Q34613425 | ||
MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells | Q34773770 | ||
Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth | Q35089015 | ||
The emerging roles of YAP and TAZ in cancer | Q36035567 | ||
Diet-induced obesity potentiates the growth of gastric cancer in mice | Q36409245 | ||
The Roles of SIRT1 in Cancer | Q37150510 | ||
Obesity as a major risk factor for cancer. | Q37171959 | ||
Nampt: linking NAD biology, metabolism and cancer | Q37334248 | ||
The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer | Q37661186 | ||
Nampt/PBEF/visfatin and cancer | Q37774515 | ||
The Hippo pathway in biological control and cancer development | Q37800053 | ||
The dual role of sirtuins in cancer | Q37937462 | ||
Obesity, adipokines and cancer: an update. | Q38267868 | ||
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment | Q38365509 | ||
SIRT1/PGC1α-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer | Q38465646 | ||
Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target. | Q38835509 | ||
The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma. | Q38904795 | ||
Diet-induced obesity promotes murine gastric cancer growth through a nampt/sirt1/c-myc positive feedback loop | Q39106286 | ||
SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma | Q39173436 | ||
Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil | Q39509326 | ||
A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents | Q42211262 | ||
Establishment of a mouse forestomach carcinoma cell line (MFC) with spontaneous hematogenous metastasis and preliminary study of its biological characteristics | Q43845666 | ||
Human SIRT1: a potential biomarker for tumorigenesis? | Q44928605 | ||
Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. | Q51787226 | ||
P433 | issue | 4 | |
P921 | main subject | obesity | Q12174 |
P304 | page(s) | 4151-4157 | |
P577 | publication date | 2017-08-03 | |
P1433 | published in | Oncology Letters | Q20640514 |
P1476 | title | Obesity accelerates murine gastric cancer growth by modulating the Sirt1/YAP pathway | |
P478 | volume | 14 |
Q92633600 | Dysfunctional Mechanotransduction through the YAP/TAZ/Hippo Pathway as a Feature of Chronic Disease | cites work | P2860 |
Search more.